MTL Cannabis launches products in Australia

Executive Summary

• MTL Cannabis Corp. has officially launched its premium branded cannabis products into the Australian medical market, marking a significant milestone in its international growth strategy.
• The company is introducing specific branded strains to pharmacies across Australia, leveraging the country's rapidly growing medical cannabis sector.
• The expansion targets a market projected to double in revenue from approximately $600 million in 2024 to over $1.2 billion by 2028.

Key Details

• Product Launch: MTL Cannabis is launching its premium branded products into Australian pharmacies.
• Specific Strains Launched:
  • Sage n' Sour
  • Strawberry n' Mintz
  • Wes' Coast Kush
  • East Coast Dank'z
  • Frosted Flakes
  • Larry
  • Peanut Butter Gelato
• Market Context: The Australian medical cannabis market is experiencing strong momentum, with revenues projected to double from around $600-million in 2024 to more than $1.2-billion by 2028 (source: Prohibition Partners' fifth edition of The Global Cannabis Report).
• Strategic Goal: This move supports MTL's international growth strategy and aims to replicate its success in Canada within the Australian market.

Notable Quotes

• "We're thrilled to introduce the MTL brand to Australia," said Michael Perron, chief executive officer of MTL. "Our success in Canada is built on consistently delivering quality products that resonate with consumers. We're confident our commitment to excellence will be equally well received in Australia."